Table 2.
Age-standardized prevalence (95% CI) of comorbidities in men and women with gout at the time of first diagnosis
| Gout cases (N = 14,113) |
||||
|---|---|---|---|---|
| Men (N = 9513), prevalence (%) |
95% CI | Women (N = 4600), prevalence (%) |
95% CI | |
| Comorbidities suggested to increase SU level | ||||
| Psoriasis | 3.7 | 2.8–4.5 | 3.3 | 2.6–4.1 |
| Organ transplantation | 1.3 | 0.8–1.8 | 1.8 | 0.9–2.6 |
| Renal disease | 8.2 | 7.4–9.0 | 8.3 | 6.8–9.8 |
| Use of diuretics | 21.9 | 20.9–22.8 | 24.1 | 22.7–25.6 |
| Obesity | 10.2 | 8.9–11.6 | 12.5 | 10.8–14.3 |
| Alcoholism | 5.5 | 4.7–6.3 | 3.5 | 2.1–4.8 |
| Other comorbidities | ||||
| Diabetes | 8.7 | 8.1–9.3 | 9.9 | 8.9–10.9 |
| Hypertension | 40.1 | 38.6–41.6 | 39.4 | 36.9–41.9 |
| Coronary heart disease | 9.4 | 9.0–9.9 | 6.4 | 5.8–7.0 |
| Congestive heart failure | 7.7 | 7.3–8.1 | 6.6 | 6.0–7.1 |
| Atrial fibrillation | 9.0 | 8.4–9.5 | 6.0 | 5.4–6.5 |
| Stroke | 4.1 | 3.7–4.5 | 3.3 | 2.8–3.7 |
| Thromboembolism | 5.2 | 4.8–5.6 | 6.6 | 5.8–7.5 |
| Peripheral vascular disease | 2.1 | 1.9–2.3 | 2.1 | 1.7–2.5 |
| COPD | 2.4 | 2.1–2.6 | 3.1 | 2.6–3.5 |
CI confidence interval, COPD chronic obstructive pulmonary disease, SU serum urate